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ABSTRACT
Spermatozoa survivability is of utmost importance in delivering equine semen for
artificial insemination. Semen extender supplementation may allow for increased
survivability. L-carnitine (CARN) has been studied for its role in the mobilization of fatty
acids. Two experiments (EX1/EX2) assessed the effects of CARN and pyruvate (P) on
spermatozoa survival. Total (TM) and progressive motility (PM), velocity and direction
of movement (VAP, VSL, VCL, and elongation) were assessed by CASA, membrane
status (SYBR 14/PI stains) and acrosome status (FITC-PSA stain) by flow cytometer. In
EX1, 4 ejaculates were collected from 2 stallions. Aliquots were diluted in skim-milk
glucose extender (SKMG) or INRA 96 (INRA) with and without CARN and P added at
levels of 0.00806 g/mL and 0.0011004 g/mL. Split aliquots were placed in separate
Equine Express II™ containers for CASA after 2 hours, 24 hours, and 48 hours. Flow
cytometery was conducted at 24 hours. In EX 2, 4 ejaculates were collected from 3
stallions. Aliquots were diluted in SKMG, INRA, and Revolution (REV) with or without
CARN+P. In EX1/EX2 dilution in INRA resulted in higher motility compared to dilution
in other extenders (p<0.05). In EX1 CARN+P (p<0.01) improved TM and PM. Intact
membrane percentages were higher (p<0.05) for with CARN + P (74.3% with vs. 71.7%
without). In EX2 CARN+P (p<0.05) improved TM and PM and also improved (p<0.05)
percentage of intact membranes (78.0% with vs. 75.0% without) and intact acrosomes
(78.9% with vs. 66.2% without). In conclusion, addition of L-carnitine + pyruvate may
improve multiple factors of spermatozoa survival.
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INTRODUCTION

Justification
In the field of equine fertility and reproduction, overall survival of spermatozoa
after suspension in extender is of utmost importance and concern in the effectiveness of
providing viable and motile semen for artificial insemination. A majority of infertility
issues within the male sex of a species are related to spermatozoa malfunction (Sikka,
1996.).
Processing techniques have profound impact on semen characteristics. Some of
these processes include cooling, freezing, dilution, and the process of centrifugation to
remove the seminal plasma.
Different compounds have been tested as supplemental components for semen
extenders and assessed for their ability to increase post-storage survival for both cooled
and frozen equine spermatozoa. Since the science of artificial insemination was first
developed items such as skim milk, glucose, glycerol and egg yolk have been used to aid
in preservation of equine, bovine, caprine, ovine, and human spermatozoa. Carnitine (Lcarnitine specifically) and pyruvate are two pivotal compounds for overall health and
bodily function. This study was conducted to further assess the roles they play in survival
of spermatozoa and to determine if they are an asset in equine semen handling,
preservation, shipping and effectiveness once delivered in utero.
Spermatozoa differ greatly from other cells in the stallion. Although spermatozoa
function and survival is often assessed post-ejaculation, modifications and damages to its
ability to perform can happen throughout generation and maturation within the stallion.
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According to Amann and Graham (Equine Reproduction, 1993), the ability of
spermatozoa to successfully fertilize the egg depends on five factors:
1. Spermatozoa must have the ability to produce energy through metabolism.
2. Spermatozoa must be progressively motile.
3. The acrosome and the enzymes within must have the ability to break down
and penetrate the wall of the ovum.
4. There must be adequate lipid availability within the membranes for prefertilization stability and capacity for membrane fusion when the spermatozoa
and oocyte connect.
5. Proteins that are necessary for survival in the mare tract and for spermatozoa
to egg attachment must be present.
Although the concept of fertilization is simple in theory, the constituent pieces
that allow for a successful pregnancy can be complex. When studying the male of any
species, there are a significant number of factors that contribute to fertility. The difficulty
in semen research is the lack of a singular technique that can be applied across all the
males of one species. This issue is derived from the variation not only across breeds but
also within breeds. In the equine, different breeds have been developed for their abilities
in certain disciplines and events. The characteristics that are selected are usually related
to these abilities rather than to reproductive efficiency.
This study evaluated motility, velocity, membrane status and acrosome status of
the spermatozoa at increasing time increments post collection (2 hours, 24 hours, 48
hours). The practical application of this study was to ascertain the effectiveness of Lcarnitine and pyruvate in their ability to help with the longevity of the sample as is
necessary for the 2-3 day time frame required for shipping frozen or cooled equine
semen.
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Problem Statement and Objective
Delivery of viable and motile equine spermatozoa for artificial insemination can
be difficult due to the varying shipping schedules of mail carriers. In order for
spermatozoa to stay viable over the two to three day shipping time, spermatozoa must be
suspended in extenders that provide adequate energy and protection. The objective of this
study was to determine the effects of L-carnitine and pyruvate on motility, velocity,
membrane status and acrosome status of cold stored stallion spermatozoa when added to
diluents in commercially available equine semen extenders.

Null Hypotheses
1. L-carnitine and pyruvate supplementation of semen extenders will have no
effect on motility, velocity, membrane status and acrosome status for stallion
spermatozoa.
2. There will be no difference in effects among extenders.
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LITERATURE REVIEW

Spermatozoa Structure
The general structures of spermatozoa are the plasma membrane, head, neck,
midpiece, principal piece and end piece. The structures of focus within this literature
review are the plasma membrane, head and midpiece.
The lipid bilayer, the phospholipid-water interface, and the glycocalyx comprise
the three zones of the plasma membrane. Within the lipid bilayer are inward facing fatty
acyl groups, which are the hydrophobic polar phospholipids, as well as outward facing
charged polar head-groups, which are hydrophilic in nature. The most common lipids in
the plasma membrane are phospholipids and cholesterol.
Proteins are likewise a significant part of the plasma membrane and make up
approximately 50% of its matter (Dupuy et al., 2007). Integral proteins provide
necessary structure while peripheral proteins can be easily removed or replaced. Integral
proteins may also serve as pores, channels and receptors for media based substrates.
Often times these proteins have carbohydrate chains, which have the ability to bind with
medium-based proteins due to the net negative charge of the carbohydrate chain.
Properties and composition of the glycocalyx have the potential for change
depending on the effects caused by the addition of new material attaching to the
carbohydrate chains of the integral proteins. Within the plasma membrane in stallions,
the ratio of cholesterol to phospholipid is 0.36 (Parks and Lynch, 1992). The major
classes of phospholipids in the spermatozoa of most domestic species are: choline,
ethanolamine, and sphingomyelin (Amann and Graham, 1993). The cholesterol to
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phospholipid (specifically those phospholipids that contain polyunsaturated acyl side
chains) ratio generally characterizes the fluidity of the membrane. Higher levels of
cholesterol will make the membrane more rigid. Proper cholesterol levels maintain the
integrity of the bilayer. Most of the plasma membrane attachment is around the tail of
the spermatozoa. There are not a significant amount of attachment points that rigidly join
the plasma membrane to the head of the spermatozoa (Aman and Graham, 1993).
The main regions of the head of the spermatozoa cell are the plasma membrane,
the post-acrosomal lamina, the acrosome, the nuclear envelope and the nucleus (this is
from the outer-most region to the innermost region). In stallions, the head is wide and
mostly flat. The head generally tapers down from a thicker region near the midpiece to a
thinner region approaching the rostral tip of the cell. The enzymes housed in the
acrosome, which are responsible for the penetration of the oocyte, are hyaluronidase,
proacrosin, acrosin, and varying lipases. A feature known as the perfatorium can
sometimes be observed in the rostral tip of the acrosome and is believed to help provide
structure. The structures in the plasma membrane allow the spermatozoon to attach to the
zona pellucida of the ovum, which catalyzes the beginning of the acrosome reaction
(Flesch and Gadella, 2007).
The region from the base of the neck to the annulus is known as the midpiece.
The matrix of mitochondria is held within this area of the spermatozoa cell.
Approximately 50 helical turns (known as gyri) of mitochondria exist in the typical
stallion spermatozoon. A series of nine fibrous structures extend through the midpiece
and provide the mechanical ability for movement. The axoneme is in the central most
region of the tail and is responsible for giving spermatozoa the potential for propulsion.
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The annulus conjoins is a significant apparatus in joining the head and the tail of a
spermatozoon (Gadella et al., 2008).

Spermatozoa Metabolism
The study of spermatozoa metabolism helps discover the function of spermatozoa
and the specific characteristics that need to be addressed to aid in preservation and
survivability. Spermatozoa, like other cells, must receive energy in the form of adenosine
tri-phosphate, or ATP. Spermatozoa have the ability to utilize aerobic and anaerobic
pathways for energy production. The breakdown of glucose, lactate, and pyruvate as well
the oxidation of amino acids and lipids are the subsidiary components of spermatozoa
metabolism. Diffusion may provide substantial energy for flagella in species that produce
spermatozoa of a smaller size; however, diffusion does not provide enough energy (ATP)
through the mitochondria for continued function of the flagellum in species with larger
spermatozoa (Ford, 2005). This energy conundrum can be solved in part through the
quick delivery of ATP through the use of the adenylate-kinase shuttle (Ford, 2005). The
presence of lactate within a population of spermatozoa is a player in spermatozoa
metabolism. Lactate has historically been condemned as metabolic waste, but is now
being classified as an essential component of cell metabolism as well as a player in
intercellular and intracellular redox reactions (Gladden, 2004). There is some correlation
in the production of L-lactate and overall spermatozoa survival. In swine, the production
of L-lactate and the ratio of insemination to farrowing show a “relatively high
correlation.” (Rigau et al.,1996).
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Cholesterol
The focus of this study was on the effects of L-carnitine and pyruvate; however,
knowledge of the role of cholesterol in the overall production of ATP due to its influence
over the process of fatty acid oxidation is essential. Unsaturated fatty acids are present in
large quantities in the membranes of spermatozoa cells in mammals (Sikka, 1996). As an
integral component of structural integrity and survivability of spermatozoa, fatty acids
must be maintained at adequate levels and ratios. Intracellular fatty acids act as an
energy source for spermatozoa as they can be oxidized to generate ATP for energy for the
spermatozoa cells. Subsequently, a lack of fatty acids will result in lack of substantial
ATP production. Lack of ATP means lack of motility for spermatozoa, lack of motility
leads to lack of ability to fertilize an egg and thus an overall reduction in conception rates
of females can occur.
One important cholesterol-binding molecule is known as HBCD (2hydroxypropyl-2-cyclodextrin). This molecule has the capacity to serve as a sink or a
shuttle for cholesterol, depending on its current environment, which can subsequently
raise or lower the concentration of cholesterol in the plasma membrane of the
spermatozoa (Galantino-Homer et al., 2006). A higher ratio of cholesterol to
phospholipids lowers the risk of cold shock to the spermatozoa.
A major issue with adding fatty acid compounds to semen extender is the
hydrophobic nature of lipids that results in the inability of most fatty acid compounds to
bind and integrate with water based media. The addition of cyclodextrins to a
hydrophobic compound can allow for the compound to change its nature and become
hydrophilic. This process is conceptually simple. A cyclodextrin is a cyclic sugar
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molecule that can attach itself by surrounding another compound. When the cyclodextrin
surrounds a lipid molecule, such as cholesterol, it allows the cholesterol to integrate with
the water. The ability to add these fatty acids to semen extenders increases available
substrates for spermatozoa metabolism. A study on cholesterol (Christian et al., 1999)
found that adding cyclodextrins at low levels to serum serves as a catalyst for a
cholesterol shuttle that can transport cholesterol from cells to the lipoproteins within the
serum. As a result, cyclodextrins possess the ability to manipulate the metabolism of
cholesterol. The highest efficiency cholesterol shuttle in the tests conducted was the
“double-decker” cyclophane.
The ratio of cholesterol to phospholipids in an ejaculate is highest directly after
ejaculation and decreases over time (Cross, 1998). When spermatozoa are being
capacitated, protein acceptor cells obtain the cholesterol that is released from the
membrane of the spermatozoa while phospholipids are being brought in. The most
important and abundant sterol in an ejaculate is cholesterol. Density of cholesterol in the
membranes of spermatozoa differs significantly across species. The recovery of motile
spermatozoa post-thaw is improved when exogenous cholesterol is administered to the
membranes of the spermatozoa prior to freezing (Purdy et al., 2004).

Carnitine
Carnitine was named from the Latin word carnus, which means meat, because
meat was the first location in which the compound was discovered. Different groups of
Russian and German scientists discovered carnitine (the Russian fraction being credited
with the initial isolation) in 1905. In 1948, scientists realized the necessity of this
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compound in the survival of the larvae of mealworms. They did not know that the
compound they were dealing had been previously discovered and so it was dually named
as vitamin BT until they later identified that this “vitamin Bt” was not fully functional as a
vitamin and had already been classified as carnitine (Harmeyer, 2002). The preliminary
findings on the function of carnitine as a fatty acid transporter were conducted in the late
1950’s. For many years, scientists questioned which isomer of the compound was
biologically active. L-carnitine was accepted as the biologically significant isomer in
1962 and the early studies of the effects of carnitine deficiency were conducted in the
early 1970’s.
Carnitine is a quaternary ammonium compound. The proper chemical name of Lcarnitine is 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium. L-carnitine has
seven carbon atoms, fifteen hydrogen, one nitrogen, and three oxygen; lending the
chemical formula of C7H15NO3 . In comparison to many organic molecules that exist
within the body of an animal, carnitine is not a large compound.
L-carnitine is mainly produced in the kidneys and the liver. Carnitine does not have to
be directly consumed in the diet of most mammals in order to maintain adequate levels
for bodily function. The chief derivatives of carnitine are lysine and methionine (Higdon,
2002).
At most, there is only a variance of two carbon atoms, four hydrogen atoms, one
nitrogen atom, one oxygen atom, and one sulfur atom when comparing these three
molecules on any level. Most species create their own carnitine by a process that adds a
methyl group to the amino acid lysine known as methylation (Bremer, 1983).
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Carnitine plays a pivotal role as a transporter in the process of long-chain fatty
acid oxidation (Hoppel, 2003). Carnitine transports acyl groups to the mitochondrial
stations within a cell once Β-oxidation of these long-chain fatty acids has occurred. Once
these acyl groups have arrived at the mitochondria, they are used for the production of
acetyl-CoA, which can be used in the citric acid cycle for the production of ATP (Figure
1). Acetyl groups can also be transported within the cell. Carnitine acetyl-transferase
converts acetyl-CoA into acetyl-carnitine in a process known as the acetyl-carnitine
shuttle (Hynes et al., 2011). To condense, carnitine aids in taking fatty acid substrates and
mobilizing them for energy production by the cell (Childress et al., 1967). Carnitine is
not only helpful in fatty acid metabolism, but is completely necessary for the process of
oxidation of these molecules. In order for oxidation of fatty acids (specifically within
skeletal muscle) to occur; there must be adequate levels of carnitine present. Within the
mitochondrial matrix of a cell, species that use fatty acids for energy supply during flight,
such as the common fly, must have high levels of carnitine to support and sustain this
function. However, species like the bee that utilize carbohydrates instead of fatty acids
for this same function, do not need the same supply of carnitine (Childress et al., 1967).
A study on prematurely weaned swine conducted by showed that overall
metabolism of lipids was increased when swine were given exogenous L-carnitine. The
summary of data and research on L-carnitine suggests that the oxidation/metabolism of
fatty acids is greatly improved due to the ability of L-carnitine to serve as an efficient
transporter of metabolic substrates (Coffey et al., 1991). However, it should be noted that
in a study of the effects of oral L-carnitine on semen quality in boars, no significant
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(p<0.05) treatment effects were observed in the control diet versus a 500 mg per day
supplemental diet (Kozink et al., 2004).
Carnitine deficiencies lead to less efficient mobilization of fatty acids, decreased
ATP production due to the lack of substrates available for ATP production, and the
inability to oxidize lipids at a significant rate. Carnitine has great influence on heart
health (Lango et al., 2001). Although carnitine deficiency did not have an effect on
cardiac function when observed on a short time scale in humans, an extended period of
time with insufficient levels of carnitine could cause weakened performance of the heart
and irregular patterns of function (Paulson, 1998). The ability of the heart to contract
with adequate strength and timing is especially reduced while performing under
strenuous circumstances. In relation to the function of carnitine in fatty acid metabolism,
Paulson predicts that these low levels of carnitine lead to an inability of the cells within
the heart to produce enough ATP to sustain proper energy output for contraction
(Paulson, 1998). A study on ischemic swine hearts showed that high levels of carnitine
increase the ability of the cells to oxidize free fatty acids which may aid in removing
these extra fatty acids from the cardiac cycle thus increasing the performance and health
of the animal (Liedtke et al., 1981). Carnitine deficiencies not only result in insufficient
ATP production, as was observed in the Paulson study, but also in the inability of the
system to rid itself of excessive amounts of free fatty acids that may be deleterious to
overall function and performance of the heart.
Human supplementation has become the most popular and widely applied area of
carnitine use. The role that carnitine plays in fatty acid metabolism makes it highly
attractive to people desiring to be efficient in the burning of lipids during exercise and the
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use of these lipids as a source of energy (Brass, 2000). This same research suggests that
carnitine may positively affect the balance of glucose within the system, biosynthesis of
acyl-carnitine, and the ability of muscle to have longer endurance against fatigue
(Roberts et al., 2004). These exercise physiology researchers admit that more in depth
and controlled trials are necessary to determine the absolute results of supplemental
carnitine on overall bodily performance during exercise.
Oral L-carnitine supplements have been shown to increase spermatozoa motility
in humans when administered in a 3 to 4 month clinical trial (Higdon, 2002). Added
carnitine is hypothesized to aid in the prolonged survival of spermatozoa cells by
increasing the ability of the individual spermatozoa to mobilize its fatty acids for
sustained energy production. This sustained energy production results in spermatozoa
that stay viable and motile, meaning they have the ability to successfully fertilize an egg
for a longer period of time. Few studies have been conducted on the effects of carnitine
with the stallion but there has been evidence that seminal carnitine may serve as a
potential semen quality marker and that carnitine may improve spermatozoa survival
during storage (Stradaioli et al., 2000).
Research interest in carnitine has increased significantly from its earliest
discovery and isolation to its most recent applications as a supplement for metabolic,
cardiac and reproductive health and efficiency. From the time that it is biosynthesized
until it completes its role in transporting substrates for fatty acid oxidation, carnitine is an
essential player in the bodily function of most mammals. Although there are visible
effects of deficiencies and observed improvements with supplementation, much research
still needs to be conducted on the molecule that we know as carnitine.
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Figure 1. The role of L-carnitine in the production of ATP and substrate transfer between
the cytosol and mitochondrial matrix. (Roberts et al., 2004).

Semen Processing
When handling and processing semen for packaging, transport and use for
breeding mares there is a significant effect on the survivability of the spermatozoa based
upon the procedures and processing techniques used.
Using a centrifuge to remove the seminal plasma from an ejaculate is one of the
most common techniques and procedures used in semen processing. The amount of
seminal plasma in an ejaculate is reduced to less than 5% of the original volume after
centrifugation. Removal of seminal plasma for cold storage is not as much of a routine
procedure in Europe as it is in the United States, leading to decreased spermatozoa
survival and fertility when shipping cold stored semen (Johannisson et al., 2009).
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Centrifugation of semen in the equine is used to increase the concentration of
spermatozoa within the ejaculate (Edmond et al., 2012). Greater motility, viability,
spermatozoa chromatin integrity in treated compared to untreated samples (Johannisson
et al., 2009). In contrast, the body of centrifugation research shows individual animal
variation in their response to centrifugation. Two common centrifugation techniques are
known as centrifugal fractionation and cushioned centrifugation. The technique of
centrifugal fractionation is observed to enhance overall spermatozoa survival as it relates
to motility, acrosome status and morphology (Edwards et al., 2012). The process of
cushioned-centrifugation has the ability to collect large volumes of spermatozoa per
ejaculate (Waite et al., 2008).
Factors as seemingly unimportant as the shape of the tube that the sample is
centrifuged in can also play a significant role in overall spermatozoa survival. For
example, recovery rate of the spermatozoa may be higher in tubes with a conical base,
but overall spermatozoa survival values are greater when the tubes with the nipple base
are used while being centrifuged (Waite et al., 2008). Tube size can also have significant
effects on spermatozoa survival. Spermatozoa handled in 50-ml tubes recover slower and
have lower velocities than do spermatozoa handled in 15-ml tubes (Webb and Dean,
2009). Volumes and concentrations of spermatozoa in extender likewise effect
spermatozoa characteristics. When the percent seminal plasma in the sample is high,
overall ratios of progressively motile spermatozoa are reduced (Dawson et al., 2000).
Similarly, excessive amounts of semen per tube centrifuged can be damaging to
spermatozoa. When volumes of semen are centrifuged at levels less than or equal to 20
ml, overall loss of spermatozoa is reduced (Ferrer et al., 2012). In addition, raising the
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amount of spermatozoa in the sample to15-ml per tube may be deleterious to the recovery
of spermatozoa (Edmond et al., 2012).
Temperature at which spermatozoa are stored as well as sequence of cooling and
thawing contributes to spermatozoa survival. When semen is stored close to the 0C
level, DNA integrity and overall spermatozoa motility is reduced, compared to the result
that spermatozoa remained quite viable over a 22-hour period when kept in conditions
that ranged from 4C to 15C (Vidament et al., 2012). Progressively motile spermatozoa
are shown to decrease after semen is thawed when samples are cooled prior to
centrifugation (Squires et al., 2001). The process of centrifugation might briefly disrupt
the spermatozoa membrane; however, further tests showed that they returned to normal
after 48 hours (Johannisson et al., 2009).
Several different types of semen extenders have been used as the general medium,
pre-supplementation of other compounds, for the suspension of equine spermatozoa.
Overall, INRA 82 (INRA and IMV-Technologies. L'Aigle, France) was shown to be a
more adequate semen extender versus alternative treatments (Ijaz et al., 1995). When
using INRA 82 and Kenney’s extenders (Reproduction Resources, Walworth, WI) overall
spermatozoa survivability was greater to the 96-hour (INRA 82) and 48-hour (Kenney’s)
markers when the compound taurine was added to the extender. Survivability of
spermatozoa (cleaned and housed in Sp-Talp) that are incubated beforehand in extenders
with taurine added increases (p<0.05) an extra 12 hours (INRA 82) or 24 hours
(Kenney’s). The most current INRA extender is INRA 96 and is an improvement upon
the original INRA 82.
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The flow cytometer is a machine used for the analysis of spermatozoa at a rate of
thousands of cells in a matter of seconds. When an ejaculate is collected and suspended
in extender it can be inserted into the flow cytometer for analysis. A flow cytometer
functions by stimulating individual cells to align one after another and pass through the
reading apparatus. The cells are exposed to a variety of dyes, depending on what factors
the researcher desires to observe, in order for the machine to read specific characteristics.
A high-energy beam of light or laser stimulates the cells to assort them in a single-file
stream. Some of the traits that can be assessed by a flow cytometer are membrane status,
acrosome status, sex, volume, size, mitochondrial status, apoptosis indicators, presence of
ROS (reactive oxygen species), damaged DNA and spermatozoa capacitation (Marchetti
et al., 2001). This technology is often used in the medical field to look for disorders
within the blood, cancer markers and other medical indicators but has been widely
adapted for use in reproductive and fertility research and practice.
Most recently, flow cytometers are being calibrated to sort semen by sex of
individual spermatozoa. This practice is becoming more widely used in the cattle
industry. The equine industry is beginning preliminary work on the use of the flow
cytometer for sex-sorting stallion semen; however, there has been some difficulty (Gibb
et al., 2010) This issue arose from the inability of the flow cytometer to recognize
differences due to the opaque nature of the extenders (skim milk, egg yolk, etc.). When a
more transparent semen extender was used instead of skim milk, there was a significant
increase in the efficiency of sex sorting by the flow cytometer (Gibb et al., 2010).
Flow cytometers have been used to look for spermatozoa that have suffered
damage to their chromatin. An assay known as the DNA Fragmentation Index (DFI) is
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positively correlated with lower fertility, decreased conception rates, and increased
“spontaneous miscarriage” in humans (Virro et al., 2004). A myriad of problems still
exist with flow cytometers that necessitate further study or investigation.
Cost issues can exist with technologies for each machine. For instance, specific
lasers can only excite certain dyes. Purchase of multiple dye-specific lasers is costly.
Cost of the machine itself is also quite heavy, many machines starting around the $50,000
range. Operator efficiency and accuracy is of paramount importance with flow
cytometers. Using the wrong dyes or lasers, calibrating the machine incorrectly or
improperly setting parameters through the machine’s software can completely ruin an
analysis or give inaccurate results. Electronic interference from other machines near the
flow cytometer can likewise cause issues. When using dyes, it is important to know how
different dyes affect one another. For instance, there can be fluorescent crosscontamination of dyes or complete blocking of the effectiveness of one dye by another
dye.
The machine can also produce a series of false results depending on the scenario.
It is important to analyze spermatozoa by human quantification through a microscope
(subjective analysis) along with the use of the machine (flow cytometers, CASA
machines, etc.) to verify machine settings and accuracy (Johannisson et al., 2009). In
CASA analysis a correlation of r=0.65 was observed between “subjective” analyzed
spermatozoa and CASA analyzed spermatozoa, showing good calibration of the CASA
machine (Johannisson et al., 2009). Some dyes are designed to stain the acrosome to
check for acrosome status; however, over-damaged acrosomes lose their receptors that
act as binding sites for the dye. A completely damaged acrosome cannot absorb the dye,
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just as a completely intact acrosome would. Misreading debris within the sample can
cause false-positive or false-negative results. Bacteria that have membranes similar to
spermatozoa are often counted as spermatozoa by the flow cytometer leading to an over
estimation of viable cells. Similar misreading can occur in the machine from blood,
epithelial cells, gel and extender particles that are present in the sample.
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METHODS

Experiment 1
Collection and Processing. Four ejaculates from each of two stallions (1
American Quarter Horse, 1 Miniature horse) were collected using an artificial vagina
(AV) and the semen passed through a filter into the collection bottle. Directly after the
collection, the gel portion of the ejaculate was once again filtered off of the semen if
necessary. Semen was then analyzed for volume (mL) and concentration (million
spermatozoa per mL) using a 590B Densimeter (Animal Reproduction Systems, Chino,
CA). Semen was then divided into two sets of four test tubes, half of which were
centrifuged at 350 g-force for two to four minutes depending on visual estimation of
proper effects of centrifugation.
Extenders were prepared and frozen for use throughout the experiment. Two
different extenders were used for Experiment 1, Kenney’s SKMG (K) and INRA 96 (I).
Base tubes were labeled as A1-A8 for stallion 1 (QH) and C1-C8 for stallion 2 (MH) and
were comprised of one of the two extenders (K or I), centrifuged or non-centrifuged (S
for centrifuged), and supplemented with L-carnitine and pyruvate or not supplemented (C
for carnitine and pyruvate). Labels were as follows: 1: K, 2: KS, 3: KC, 4: KCS, 5: I, 6:
IS, 7: IC, 8: ICS. Treatment numbers were also preceded with A or C for stallions 1 and
2 respectively. Carnitine was added to the extender at the rate of 1.612 grams per 200
mL of extender. Pyruvate was added at the rate of 0.22008 grams per 200 mL. INRA 96
is delivered in 200 mL bottles, hence the 200 mL basis. The sterile water portion of
Kenney’s is delivered in 92 mL bottles; therefore, the amount of Kenney’s extender was
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doubled to make 184 mL and then 16 mL of distilled water was added to create an equal
volume to add carnitine and pyruvate to both extenders.
Extenders were thawed prior to collection of the stallions and were quality
controlled to a temperature of 30C to 35C before semen was added to ensure that the
spermatozoa did not undergo cold shock. Each sample was extended from 3:1 (extender:
semen) to 5:1 depending on the concentration of the sample to ensure that there were at
least 300 million spermatozoa per test tube. Each test tube (A1 through A8 and C1
through C8) was then divided into four 1-½ mL aliquots to be used as the four subsamples for analysis. The four sub-samples of each treatment were placed in Equine
Express II™ containers for cooling and were labeled for computer assisted sperm
analysis (CASA) at 2 hours, 24 hours, and 48 hours post-collection and for flow
cytometer analysis at 24 hours post-collection.
CASA. Each sample was inverted by hand to ensure proper mixing when
removed from the cooling containers. Droplets were taken from each sample with a
micropipette and placed on 20 micron 4 chamber slides. Slides were placed on a slide
warmer for five minutes to ensure that spermatozoa thawed to full motility and were no
longer experiencing the effects of cooling. Each chamber was then assessed by CASA
and results were recorded manually. The parameters assessed by CASA were total
motility (TM), progressive motility (PM), average path velocity (VAP), straight-line
velocity (VSL), curvilinear velocity (VCL) and elongation (ELONG).
Flow Cytometer. Each sample was vortexed on a Fisher Vortex Genie 2
(Scientific Industries Inc. Bohemia, NY) for one to two seconds to ensure the sample was
mixed homogenously. Samples of 50 L were taken from each treatment’s base tube
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using a micropipette and placed into 1 mL tubes for staining and preparations for the flow
cytometer. Three different stains were used. Intact membranes and disrupted membranes
were assessed using SYBR14 and Propidium Iodide (PI) stains. FITC-PSA was used to
stain for reacted acrosomes (unstained cells signified acrosomes that were not yet
reacted). 16 tubes were used for each ejaculate (8 for SYBR14/PI and 8 for FITC-PSA).
A quantity of 5 L of SYBR14 and 5 L of PI was added to each of 8 samples of 50 L
of semen. Treatments were vortexed for one to two seconds and then placed in a cabinet
to incubate in the dark for 20 minutes. 10 L of FITC-PSA were added to each of 8
samples of 50 L of semen. Treatments were vortexed for one to two seconds again and
then placed in a cabinet to incubate in the dark for 10 minutes. FITC-PSA is extremely
time sensitive and caution must be taken to not over-stain the samples. After the
incubation period, 100 L of Ham’s 10 HEPES diluent was added to each sample and
then samples were once again vortexed for one to two seconds prior to flow cytometer
analysis. Samples were then run through the flow cytometer and results were recorded
manually and within the memory of the computer.

Experiment 2
Collection and processing. Four ejaculates from each of three stallions (2
Arabians (A), 1 Miniature horse) were collected in the same manner as described in
Experiment 1. Volume and concentration were recorded in the same manner as
Experiment 1. Three different extenders were prepared and frozen for use throughout the
experiment. Extenders used were EZ-Mixin (Animal Reproduction Systems) SKMG (K),
INRA 96 (I), and Revolution (Santa Cruz Biotechnology, Dallas, TX) SKMG (R).
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Centrifugation was eliminated from Experiment 2 due to the deleterious effects
of centrifugation observed in some of the stallions during Experiment 1. Treatment tubes
were labeled as C1-C6 for stallion 1 (MH), T1-T6 for stallions 2 (A), and X1-X6 for
stallion 3 (A). Treatments consisted of one of the three extenders and were either
supplemented with carnitine/pyruvate combination as in Experiment 1 or were not
supplemented. Carnitine/pyruvate supplemented extenders were annotated with the label
of (+). Treatment labels were as follows 1: K, 2: K+, 3: I, 4: I+, 5: R, 6: R+. Treatment
labels were also preceded with C, T, or X for stallions 1, 2, and 3. In this experiment,
distilled water was not added to the extenders to equal the 200mL that we standardized
from the INRA 96 volume. Concentration per unit volume; however, was standardized
from Experiment 1 to Experiment 2 and was equivocated to the ratio of 1.612 grams of
carnitine and 0.22008 grams of pyruvate per 200mL volume of extender. All further
processing of semen was done according to the protocol described in Experiment 1.
CASA. CASA analysis was conducted according to the same procedures and
protocols discussed in Experiment 1.
Flow Cytometer. Flow cytometer analysis was likewise conducted according to
the procedures and protocols discussed in Experiment 1.

Statistics
The GLM procedure of ANOVA was used in Minitab for treatment analysis.
Tukey’s pairwise comparisons were used for analysis of L-carnitine and pyruvate effects
as well as extender effects. For ANOVA, the model consisted of stallion, ejaculate
(nested within stallion) and time (nested within ejaculate).
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IACUC Compliance
These experiments were conducted in compliance with the International Animal
Care and Use Committee (IACUC) and can be found under the protocol name
“Techniques to Improve Stallion Semen Preservation.” The IACUC identification
number is 13-027.0-A.
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RESULTS

Experiment 1
Experiment 1 mean values ± standard deviations for L-carnitine and pyruvate
treated aliquots compared to untreated aliquots assessed by CASA at 2 hours, 24 hours
and 48 hours post collection and by flow cytometer at 24 hours post collection were
recorded. Total motility and progressive motility are recorded in Table 1. The effects of
VAP, VSL, VCL and elongation are recorded in Table 2. The percentage of intact
membranes (% SYBR), disrupted membranes (% PI), intact acrosomes (% unstained),
and reacted acrosome (% FITC-PSA) are recorded in Table 3. Main effects of stallion,
ejaculate (nested within stallion), centrifugation, extender, L-carnitine and pyruvate
treatment, and time are listed with p-values in Table 4. Tukey’s comparisons of Lcarnitine and pyruvate treatment effects are listed in Table 5 and Table 6. Tukey’s
comparisons of extender effects are listed in Table 7 and Table 8.
When observing L-carnitine and pyruvate treatment effect, the only statistically
different period (p<0.05) of observation was 48 hours post-collection progressive
motility. The visual means show trends; the reasons for the lack of within time difference
will be addressed within the “Discussion” section of this thesis.
Multiple significant (p<0.05) main effects existed when observed across all
stallions, ejaculates, times and treatments. Stallion effect was significant for VCL.
Ejaculate effect was significant for TM, PM, VAP, ELONG, % SYBR, % PI, %
unstained and % FITC-PSA. Centrifuge effect was significant for VAP. INRA was
superior to SKMG (p<0.05) for TM and PM. L-carnitine and pyruvate treatment effect
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was superior to control for TM and PM. Time effect was significant for TM, PM, VAP,
VSL, VCL and ELONG (note: Time was not a factor for % SYBR, % PI, % unstained
and % FITC-PSA).

Experiment 2
Experiment 2 mean values ± standard deviations for L-carnitine and pyruvate
treated aliquots compared to untreated aliquots assessed by CASA at 2 hours, 24 hours
and 48 hours post collection and by flow cytometer at 24 hours post collection were
recorded. Total motility and progressive motility are recorded in Table 9. VAP, VSL,
VCL and Elongation are recorded in Table 10. The percentage of intact membranes (%
SYBR), disrupted membranes (% PI), intact acrosomes (% unstained), and reacted
acrosome (% FITC-PSA) are recorded in Table 11. Main effects of stallion, ejaculate
(nested within stallion), centrifugation, extender, L-carnitine and pyruvate treatment, and
time are listed with p-values in Table 12. Tukey’s comparisons of L-carnitine and
pyruvate treatment effects are listed in Table 13 and Table 14. Tukey’s comparisons of
extender effects are listed in Table 15 and Table 16.
There were no significant treatment effects (p<0.05) when comparing means
across individual times. As in Experiment 1, the reasons for the lack of difference will be
addressed within the “Discussion” section of this thesis.
In parallel with Experiment 1, many main effects existed when observing means
with all stallions, ejaculates, times and treatments included. Stallion effect was
significant for TM, PM, VAP, VSL, VCL, ELONG, % unstained and % FITC-PSA.
Ejaculate effect was significant for TM, VAP, % SYBR and % PI. The INRA extender

25

was superior (p<0.05) to SKMG and REV for TM and PM. These findings are in
agreement with the literature. L-carnitine and pyruvate treatment effect was superior
(p<0.05) to the control for TM and PM. Time effect was significant for TM, PM, VAP,
VSL, VCL and ELONG (note: Time was not a factor for % SYBR, % PI, % unstained
and % FITC-PSA.
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Table 1. Experiment 1 CASA means ± SD for total motility (TM) and progressive motility (PM) across extender, centrifugation and
L-carnitine/pyruvate treatment (CP) at 2 hours, 24 hours, and 48 hours post collection.
SKMG
Not Centrifuged
CP-

CP+

INRA 96
Centrifuged

CP-

CP+

Not Centrifuged
CP-

CP+

Centrifuged
CP-

CP+

TM
65.9±19.3

79.3±11.7

70.7±16.0

75.0±11.7

76.5±13.0

78.1±13.8

73.8±10.7

78.8±11.8

24h

67.0±16.3

69.3±13.6

62.5±15.1

68.5±12.2

71.4±14.1

76.3±13.6

75.4±15.4

70.3±13.2

48h

58.6±18.8

70.0±10.0

67.9±14.9

62.4±16.9

76.6±14.9

76.3±9.7

74.5±15.2

69.5±10.4

2h

50.0±15.0

60.1±11.4

53.9±15.5

59.1±11.7

59.5±14.0

62.6±15.2

57.8±14.7

62.6±15.8

24h

47.0±14.2

56.4±13.1

48.5±16.4

59.1±11.8

53.6±16.5

59.6±13.0

59.6±18.6

55.9±13.4

48h

40.3±11.4b

52.9±7.32ab

54.8±14.2ab

59.1±11.9ab

58.5±12.9b

56.3±7.6ab

61.8±10.6a

55.1±9.2ab

27

2h

PM

Note: means and standard deviations within a row with different superscripts are different (p<0.05).

Table 2. Experiment 1 CASA means ± SD for active path velocity (VAP), straight-line velocity (VSL), curvilinear velocity (VCL),
and elongation (ELONG) across extender, centrifugation and L-carnitine/pyruvate treatment (CP) at 2 hours, 24 hours and 48 hours
post collection.
SKMG

INRA 96

Not Centrifuged
CP-

CP+

Centrifuged
CP-

CP+

Not Centrifuged
CP-

CP+

Centrifuged
CP-

CP+

VAP
2h

114.9±16.0

117.8±16.3

123.6±16.0

122.5±13.2

119.2±10.3

116.4±14.6

112.6±17.2

115.8±9.7

24h

122.2±5.8

119.0±9.7

119.7±9.9

114.2±7.1

125.0±10.5

118.9±8.0

117.7±11.9

111.7±7.4

48h

117.5±10.8

110.0±17.8

114.0±14.8

100.9±14.2

115.0±9.1

99.8±15.8

104.0±12.2

101.9±11.0

2h

96.8±14.6

97.4±14.3

100.2±14.2

103.2±13.8

100.3±10.2

99.0±14.9

91.3±15.7

97.5±11.5

24h

98.2±11.3

103.3±12.2

97.5±9.6

100.0±6.4

101.8±11.5

98.5±8.5

94.0±10.7

95.1±7.4

48h

95.0±6.1

91.1±11.4

92.7±10.5

87.4±10.6

93.4±6.1

83.9±10.0

88.4±9.4

87.4±9.6

2h

178.5±25.4

183.6±32.5

206.9±28.5

196.1±26.2

189.4±21.8

178.4±21.2

189.8±33.8

187.8±24.0

24h

204.5±11.1

196.1±39.7

204.2±27.4

182.1±22.4

205.3±29.6

193.5±31.1

202.5±28.1

181.5±24.9

48h

193.2±23.5

180.3±42.4

195.0±29.3

162.2±26.6

195.3±23.1

161.0±38.7

169.8±26.0

161.4±21.0

2h

65.5±4.3

65.1±4.7

65.3±6.1

64.8±5.1

65.1±6.1

65.8±4.5

65.9±6.1

66.0±5.4

24h
48h

62.9±3.3
63.5±4.7

64.9±3.1
64.8±4.7

62.6±3.3
64.3±4.9

64.8±4.2
65.4±4.0

62.3±3.8
64.4±4.3

65.0±2.5
64.6±5.5

64.5±2.9
65.0±5.4

63.8±3.4
64.5±3.9

VSL
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VCL

ELONG

Table 3. Experiment 1 flow cytometer means ± SD for intact membranes (% SYBR), disrupted membranes (% PI), unreacted
acrosomes (% unstained) and reacted acrosomes (% FITC-PSA) across extender, centrifugation and L-carnitine/pyruvate treatment
(CP) 24 hours post collection.
SKMG
INRA 96
Not Centrifuged
CP+

% SYBR

67.8±7.7

71.6±6.7

% PI

32.2±7.7

% unstained

% FITC

CP-

Not Centrifuged

Centrifuged

CP+

CP-

CP+

CP-

CP+

66.0±12.3

69.1±13.0

75.6±7.1

77.0±6.9

73.8±13.4

69.2±11.5

28.4±6.7

34.0±12.3

31.0±13.0

24.4±7.1

23.0±6.9

26.2±13.4

30.9±11.5

65.6±13.0

64.6±12.7

63.5±16.1

64.4±15.1

61.5±12.5

67.5±15.8

65.0±19.0

64.3±15.9

34.4±13.0

35.4±12.7

36.5±16.1

35.6±15.2

38.5±12.5

32.5±15.8

35.1±19.0

35.7±15.9

29

CP-

Centrifuged

Table 4. Experiment 1 p-values for effect of stallion, ejaculate (nested within stallion),
centrifugation, extender, L-carnitine/pyruvate (CP) and time on TM, PM, VAP, VSL,
VCL, ELONG, % SBYR, % PI, % unstained and % FITC-PSA. (Note: % SYBR, %PI,
% unstained and % FITC-PSA were not subject to multiple time analysis.
Stallion
Ejaculate
Centrifuge
Extender
CP
Time
TM

0.121

0.000

0.610

0.000

0.001

0.021

PM

0.061

0.005

0.839

0.000

0.000

0.000

VAP

0.773

0.047

0.018

0.523

0.005

0.000

VSL

0.345

0.353

0.122

0.546

0.135

0.000

VCL

0.028

0.088

0.300

0.616

0.008

0.012

ELONG

0.988

0.001

0.852

0.815

0.003

0.000

% SYBR

0.080

0.000

0.176

0.000

0.015

N/A

% PI

0.080

0.000

0.176

0.000

0.015

N/A

% unstained

0.657

0.000

0.893

0.820

0.340

N/A

% FITC

0.657

0.000

0.893

0.820

0.340

N/A
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Table 5. Experiment 1 Tukey’s comparisons of CP effect on TM, PM, VAP, VSL, VCL
and ELONG with all times and extenders included.
CPCP+
TM

70.1±15.57b

72.8±12.8a

PM

53.8±15.1b

57.3±12.1a

VAP

117.1±12.9a

112.4±14.0b

VSL

95.8±11.2

95.3±12.2

VCL

194.5±27.0a

180.3±30.9b

ELONG

64.3±4.6b

64.9±4.1a

Note: means and standard deviations within a row with different superscripts are different
(p<0.05).
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Table 6. Experiment 1 Tukey’s comparisons of CP treatment effects on TM, PM, VAP, VSL, VCL and ELONGATION by extender
and centrifugation with all times included.
SKMG

SKMG

SKMG

SKMG

INRA

INRA

INRA

INRA

Not-Cent

Cent

Not-Cent

Cent

Not-Cent

Cent

Not-Cent

Cent

CP-

CP-

CP+

CP+

CP-

CP-

CP+

CP+

63.8±17.8d

67.0±15.1cd

72.8±12.3abc

68.6±14.2bcd

74.8±13.6ab

74.5±13.4ab

76.9±12.0a

72.8±12.1abc

PM

45.8±13.7c

52.4±15.0b

56.5±10.8ab

55.3±12.7ab

57.2±14.1ab

59.7±14.4a

59.5±12.1a

57.9±13.0ab

VAP

118.2±11.5ab

119.1±13.8ab

115.6±14.9abc

112.6±14.5abc

119.7±10.4a

111.4±14.5bc

111.7±15.3abc

109.8±10.8c

VSL

96.7±10.8ab

96.8±11.5ab

97.3±13.1ab

96.9±12.4ab

98.5±9.9a

91.2±11.9b

93.8±13.1ab

93.3±10.2ab

VCL

192.1±22.8abc

202.1±27.6a

186.7±37.4abc

180.1±27.9bc

196.7±24.9ab

187.36±31.3abc

177.7±32.7c

176.9±25.1c

65.1±4.2

64.8±4.2
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TM

ELO 64.0±4.1
64.0±4.8
64.9±4.1
65.0±4.3
63.9±4.8
65.1±4.8
Note: means and standard deviations within a row with different superscripts are different (p<0.05).

Table 7. Experiment 1 Tukey’s comparisons of extender effect on TM, PM, VAP, VSL,
VCL and ELONG with all times and CP treatments included.
SKMG
INRA
TM

68.1±15.1b

74.8±12.7a

PM

52.5±13.6b

58.6±13.3a

VAP

116.4±13.8a

113.2±13.3b

VSL

96.9±11.8a

94.2±11.5b

VCL

190.2±30.0

184.6±29.4

ELONG

64.5±4.3

64.7±4.5

Note: means and standard deviations within a row with different superscripts are different
(p<0.05).
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Table 8. Experiment 1 Tukey’s comparisons of extender effects on TM, PM, VAP, VSL,
VCL and ELONGATION with all times included.
SKMG

INRA

TM

68.1±15.1b

74.8±12.7a

PM

52.5±13.6b

58.6±12.3a

VAP

116.4±13.8a

113.2±13.3b

VSL

96.9±11.8a

94.2±11.5b

VCL

190.2±30.0

184.6±29.4

ELONG

64.5±4.3

64.7±4.5
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Table 9. Experiment 2 CASA means ± SD for total motility (TM) and progressive motility (PM) across extender and Lcarnitine/pyruvate treatment (CP) at 2 hours, 24 hours, and 48 hours post collection.
SKMG
INRA 96
REV
CP-

CP+

CP-

2h

78.0±13.9

82.8±13.3

85.9±11.8

24h

77.7±17.6

80.4±15.0

48h

68.8±21.5

2h

CP+

CP-

CP+

87.8±9.7

78.0±14.6

82.8±11.9

79.1±18.3

80.8±14.9

73.8±18.3

72.6±17.1

74.3±18.4

75.4±18.9

78.7±13.5

58.3±23.0

66.4±17.8

62.3±13.3

66.2±11.9

72.2±11.0

74.2±8.1

63.8±12.1

68.7±10.0

24h

57.3±16.6

57.8±17.4

59.4±17.9

62.1±15.4

53.8±17.5

56.4±16.7

48h

46.3±18.1

52.8±17.4

54.3±17.4

59.3±13.0

42.5±17.5

47.2±15.4

TM
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PM

Table 10. Experiment 2 CASA means ± SD for active path velocity (VAP), straight-line velocity (VSL), curvilinear velocity (VCL),
and elongation (ELONG) across extender and L-carnitine/pyruvate treatment (CP) at 2 hours, 24 hours and 48 hours post collection.
SKMG
INRA 96
REV
CPCP+
CPCP+
CPCP+
VAP
2h
114.9±13.9
123.1±15.7
120.4±10.1
117.6±13.8
121.0±14.1
119.6±14.7
24h
118.3±23.1
121.0±14.2
114.5±18.5
107.0±13.6
119.3±24.4
118.2±14.6
48h
113.6±22.5
111.8±18.7
117.7±21.4
105.9±10.4
115.1±18.3
105.0±11.7
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VSL
2h
24h
48h

98.7±12.1
94.3±14.8
88.8±15.3

104.6±14.6
97.4±10.3
88.3±11.6

103.5±6.4
95.0±12.8
95.7±12.3

101.8±10.5
89.8±7.9
85.5±7.3

106.4±11.7
97.3±16.4
92.0±11.8

105.7±12.5
92.7±10.6
84.4±6.6

VCL
2h
24h
48h

181.7±19.5
204.5±45.8
200.8±43.5

192.9±26.1
214.0±33.1
202.2±43.7

186.9±22.1
190.2±38.6
203.6±46.3

178.8±28.1
178.5±35.5
184.5±33.9

182.4±23.6
204.3±49.7
208.1±154.6

117.2±25.9
190.0±34.4
190.5±35.1

ELONG
2h
24h
48h

60.8±1.9
60.7±1.8
60.6±2.2

60.8±1.3
60.4±2.4
60.8±2.6

61.6±1.2
60.8±2.1
60.3±2.3

60.8±1.5
61.3±1.7
61.3±1.6

61.5±2.2
60.3±2.1
60.2±2.1

61.2±2.0
60.5±2.6
60.5±1.8

Table 11. Experiment 2 flow cytometer means ± SD for intact membranes (% SYBR), disrupted membranes (% PI), unreacted
acrosomes (% unstained) and reacted acrosomes (% FITC-PSA) across extender and L-carnitine/pyruvate treatment (CP) 24 hours
post collection.
SKMG
INRA 96
REV
CP-

CP+

CP-

CP+

CP-

CP+

60.9±10.2

67.9±5.8

77.2±7.1

79.9±4.5

87.0±2.6

86.2±5.3

% PI

39.1±10.2

32.1±5.8

22.8±7.1

20.1±4.5

13.0±2.6

13.8±5.3

% unstained

63.0±21.2

77.9±4.6

65.8±17.6

80.7±6.4

69.8±13.7

78.0±7.3

% FITC-PSA

37.0±21.2

22.1±4.6

34.2±17.6

19.3±6.4

30.2±13.7

22.0±7.3
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% SYBR

Table 12. Experiment 2 p-values for effect of stallion, ejaculate (nested within stallion),
extender, L-carnitine/pyruvate (CP) and time on TM, PM, VAP, VSL, VCL, ELONG, %
SBYR, % PI, % unstained and % FITC-PSA. (Note: % SYBR, %PI, % unstained and %
FITC-PSA were not subject to multiple time analysis.
Stallion
Ejaculate
Extender
CP
Time
TM

0.005

0.050

0.000

0.003

0.000

PM

0.001

0.319

0.000

0.000

0.000

VAP

0.001

0.007

0.162

0.01

0.000

VSL

0.007

0.222

0.625

0.033

0.000

VCL

0.000

0.064

0.001

0.021

0.000

ELONG

0.000

0.290

0.354

0.618

0.001

% SYBR

0.224

0.012

0.000

0.028

N/A

% PI

0.224

0.012

0.000

0.028

N/A

% unstained

0.004

0.591

0.567

0.000

N/A

% FITC-PSA

0.004

0.591

0.567

0.000

N/A
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Table 13. Experiment 2 Tukey’s comparisons of CP effect on TM, PM, VAP, VSL, VCL
and ELONG with all times and extenders included.
CPCP+
TM

75.0±18.7b

78.5±15.5a

PM

56.9±17.5b

60.5±15.8a

VAP

117.2±18.5a

113.6±15.3b

VSL

96.8±13.5a

94.5±12.7b

VCL

195.8±38.5a

189.8±34.0b

ELONG

60.7±2.0

60.8±2.0

Note: means and standard deviations within a row with different superscripts are different
(p<0.05).
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Table 14. Experiment 2 Tukey’s comparisons of CP treatment effects on TM, PM, VAP, VSL, VCL and ELONGATION by extender
with all times included.
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SKMG

SKMG

INRA

INRA

REV

REV

CP-

CP+

CP-

CP+

CP-

CP+

TM

74.8±17.9bcd

79.2±15.7abc

80.1±16.8ab

82.4±13.1a

70.1±20.3d

73.9±16.8cd

PM

55.3±17.1cd

58.9±16.3bc

62.0±17.1ab

65.2±13.8a

53.4±17.8d

57.4±16.5bcd

VAP

115.6±19.8ab

118.6±16.6a

117.5±17.0a

110.1±13.4ab

118.5±19.0a

111.9±14.7ab

VSL

93.9±14.3ab

96.8±13.7ab

98.1±11.3a

92.4±10.9b

98.6±14.4a

94.26±13.3ab

VCL

195.7±38.4ab

203.0±35.2a

193.6±36.7ab

180.6±31.8c

198.3±41.3ab

185.9±31.8bc

ELONG
60.7±1.9
60.7±2.1
60.9±2.0
61.1±1.6
60.7±2.2
Note: means and standard deviations within a row with different superscripts are different (p<0.05).

60.7±2.1

Table 15. Experiment 2 Tukey’s comparisons of extender effect on TM, PM, VAP, VSL,
VCL and ELONG with all times and CP treatments included.
SKMG
INRA
REV
TM

77.0±16.9b

81.3±15.0a

72.0±18.6c

PM

57.1±16.7b

63.6±15.5a

55.4±17.2b

VAP

117.1±18.2

113.8±15.7

115.2±17.2

VSL

95.3±14.0

95.2±11.4

96.4±13.9

VCL

119.4±36.8b

187.1±34.7ab

192.1±37.1a

ELONG

60.7±2.0

61.0±1.8

60.7±2.2

Note: means and standard deviations within a row with different superscripts are different
(p<0.05).
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Table 16. Experiment 2 Tukey’s comparisons of extender effects on TM, PM, VAP,
VSL, VCL and ELONGATION with all times included.
SKMG

INRA

REV

TM

77.0±16.9b

81.3±15.0a

72.0±18.6c

PM

57.1±16.7b

63.6±15.5a

55.4±17.2b

VAP

117.1±18.2

113.8±15.7

115.2±17.2

VSL

95.3±14.0

95.2±11.4

96.4±13.9

VCL

199.4±36.8a

187.1±34.7b

192.1±37.1ab

ELONG

60.7±2.0

61.0±1.8

60.7±2.2
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DISCUSSION

Experiment 1
When data were analyzed within specific times (Tables 1-3) there was only one
point of significant treatment difference observed (PM at 48 hours). However, when
observing the means of each treatment, there are visible visual trends that show
difference between these treatments. The lack of statistical significance is most likely
due to inadequate degrees of freedom available when running the analysis of variance on
treatment differences. The small sample size is causative of the limited degrees of
freedom. Variation in the innate characteristics of our sample position may also be
causative of this. One of the greatest difficulties in equine reproduction research is lack
of uniformity in the different stallions used for a particular experiment. Similarly, there
is a lack of uniformity in different ejaculates from the same stallion (this can be partially
adjusted for by nesting the ejaculate effect within the particular stallion).
In this analysis the degrees of freedom are much higher; therefore the strength of
extender as well as L-carnitine and pyruvate treatment are visible. An increase in sample
size may result it significant differences in analysis of variance at each of the individual
storage times.

Experiment 2
The results of the Experiment 2 are similar to the results of Experiment 1.
Analysis at individual time points failed to show significant treatment effects. Limitations
due to stallion effect and ejaculate effect were likewise an issue within this experiment.
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Conversely, extender and L-carnitine and pyruvate treatment showed multiple
points of significance when including all times in the analysis of variance. The
assumption remains in this experiment that an increased sample size would have
potentially led to statistically different results across different treatments for individual
time analysis.

Limitations
Semen research can be highly sensitive to multiple extraneous factors. When
dealing with such environmentally dependent material, it is imperative to maintain
structured procedures and precise technical work to eliminate as much operator error and
environmental influence as possible. As mentioned above, the issues of stallion effect
and ejaculate effect are continuing areas of difficulty for adjustment in this research.
Characteristic differences are highly variable across breeds but they are likewise variable
within breeds.
Overall, in an increase in the number of stallions available, number of ejaculates
from each stallion and continued improvement of technical precision would have led to
an even stronger base of data to analyze the effects of extender and L-carnitine/pyruvate
treatments.
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CONCLUSIONS

The inclusion of L-carnitine and pyruvate to a variety of semen extenders has the
potential to improve the media in which spermatozoa are housed during transportation for
the purpose of artificial insemination. The response of spermatozoa to treatment is
dependent on the type of extender used. SKMG and REV may benefit from the inclusion
of L-carnitine and pyruvate while INRA seems to be optimized without the inclusion of
these treatments.
Although a larger sample size would likely have led to an increased production of
statistical significance across individual time points, the general trends in mean values
show that the addition of L-carnitine and pyruvate may improve multiple viability and
motility characteristics of equine spermatozoa.
With all times included, the significance of L-carnitine and pyruvate treatment is
strongly apparent (see p-value tables in RESULTS section). The significance of extender
is likewise strongly apparent. The addition of L-carnitine and pyruvate in diluents of
extended equine semen may significantly improve multiple factors of spermatozoa
survival analysis. The conclusion can be made that not all commercially available semen
extenders are equal. INRA 96 consistently proved to be the best extender of the ones
used in the trial (Tables 7 and 15) and often times only benefitted slightly from the
addition of L-carnitine and pyruvate treatment whereas SKMG and Revolution extenders
were inferior but improved drastically in the presence of L-carnitine/pyruvate.
Applying this knowledge may lead to an increased fertilizing capacity of a sample
of equine semen. Increasing the level of fertility for the stallion will ultimately result in
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an increased conception rate for the mares. Increased conception rates save the mare
owner money by reducing the amount of attention due to missed cycles (ultrasounds,
veterinarian checks, breeding farm fees, etc.).
All in all, stallions (specifically performance horse stallions) have been selected
for athletic ability, conformation and trainability and by default their reproductive
efficiency has gone by the wayside. More studies are necessary to say that L-carnitine
and pyruvate inclusion are absolutely beneficial to equine semen; however, this research
shows that there is strong evidence to support the use of these treatments in semen
extenders to improve the reproductive capability of the stallion by enhancing the motility
and viability characteristics of collected semen.
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